Product Images Duloxetine

NDC 31722-581-30 is a medication that comes in delayed-release capsules with a strength of 20 mg. The active ingredient in this medication is duloxetine hydrochloride. It is dispensed in a highly closed container and should be stored between 20 to 25°C (68 to 77°F). The medication guide is available at http://camberpharm.com/medicationguides. The capsules should not be chewed or crushed and should be kept out of the reach of children. The usual dosage and administration instructions can be found in the package insert. This medication is manufactured by Hetero Labs Limited in Hyderabad, India, for Camber Pharmaceuticals, Inc. in Piscataway, NJ.*

This is a medication package for duloxetine delayed-release capsules. The package contains information for the pharmacist to disperse, the usual dosage, storage conditions, and precautions for use, including not chewing or crushing the capsules and keeping them away from children. The manufacturer is Camber Pharmaceuticals, and the medication guide is available on their website. The package also includes a manufacturing license number and contact information.*

Duloxetine is a type of medication that comes in delayed-release capsules. It is also known as USP 10067 or USF 10157. Further information regarding its use or purpose is not available from the provided text.*

Each delayed-release capsule of this medication contains duloxetine hydrochloride, which is equivalent to 60 mg of duloxetine. It's important to store it at room temperature and in a tightly closed container. The medication guide with dosing and administration instructions is available, and it should not be chewed or crushed. Contact Camber Pharmaceuticals if needed. Produced by Hetero Labs Limited in Hyderabad, India.*

Duloxetine Delayed-release Capsules, USP is a medication available in a package of 90 unit dose capsules. Each capsule contains Mig.Lic. N 22/RRIAPROO1 IR 67.3mg of the active ingredient ddoreineydroctoride, USP which is equivalent to 60 mg of doroine. The capsules should not be chewed or crushed and they are not child-resistant. The medication is only available by prescription and the patient should read the provided Medication Guide before use. The NDC number for this medication is 31722-583-32.*

The chart shows the proportion of patients who experienced relapse over time from randomization to relapse measured in days. The x-axis ranges from 0 to 300, while the y-axis represents the proportion of patients who relapsed.*

This appears to be a chart comparing the percentage improvement in pain from baseline for different treatments, including Duloxeting 60mg BID, Duloxetine 60mg 0D, Duloxetine 20mg 0D, and Placebo. The x-axis shows the percent improvement in pain from baseline, while the y-axis shows the number of patients who experienced that level of improvement. However, without more context, it is not possible to say what condition or study this chart pertains to.*

The text is a chart or table showing the "Percentage of Patients Improved" with different values ranging from 210 to 280, and the "Percent Improvement in Pain from Baseline (BOCF)" shown as 0.*

The text provides a chart depicting various percentages of patients' improvement with Dulcseiass120 and the placebo. It also includes the percentage of improvement in pain from the baseline measured at 10. There is not enough information to provide further details or context.*